Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020 Read more about Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020
Q1 2020 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q1 2020 Agios Pharmaceuticals Inc Earnings Conference Call
Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency Read more about Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency
Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb Read more about Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb
Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator Read more about Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator
Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020 Read more about Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020
Agios Reports Fourth Quarter and Full Year 2019 Financial Results Read more about Agios Reports Fourth Quarter and Full Year 2019 Financial Results
Agios to Present at the Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020 Read more about Agios to Present at the Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020 Read more about Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020
Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones Read more about Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones